GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Phase 3

Withdrawn

Conditions: Infections, Papillomavirus

Interventions: Procedure: Blood sampling

First Posted Date: 2014-04-01

Last Posted Date: 2015-07-20

Lead Sponsor: GlaxoSmithKline

Registration Number: NCT02100618

Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study

Phase 4

Completed

Conditions: Epilepsy

Interventions: Drug: Lamotrigine tablets 25/100 mg

First Posted Date: 2014-04-01

Last Posted Date: 2017-11-17

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 33

Registration Number: NCT02100644

Locations: 🇯🇵
GSK Investigational Site, Tokyo, Japan

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Phase 3

Completed

Conditions: Hepatitis B
Tetanus
Diphtheria
Haemophilus Influenzae Type b
Poliomyelitis
Acellular Pertussis

Interventions: Biological: Infanrix hexa
Biological: Pediarix
Biological: Pentacel
Biological: Infanrix
Biological: ActHIB
Biological: Engerix-B
Biological: Hiberix
Biological: Prevnar13
Biological: Rotarix

First Posted Date: 2014-03-26

Last Posted Date: 2019-11-27

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 585

Registration Number: NCT02096263

Locations: 🇺🇸
GSK Investigational Site, Ellensburg, Washington, United States

Boostrix® Pregnancy Registry

Completed

Conditions: Pertussis

Interventions: Other: Data collection

First Posted Date: 2014-03-26

Last Posted Date: 2020-12-19

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 1517

Registration Number: NCT02096276

Locations: 🇺🇸
GSK Investigational Site, Research Triangle Park, North Carolina, United States

A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects

Phase 3

Completed

Conditions: Asthma

Interventions: Drug: Fluticasone Furoate/Vilanterol
Drug: Fluticasone Propionate 100 mcg
Drug: Fluticasone Furoate 100 mcg
Drug: Fluticasone Propionate 250 mcg
Drug: Fluticasone Furoate Placebo
Drug: Fluticasone Propionate Placebo

First Posted Date: 2014-03-24

Last Posted Date: 2017-05-25

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 430

Registration Number: NCT02094937

Locations: 🇯🇵
GSK Investigational Site, Tokyo, Japan

Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males

Phase 1

Completed

Conditions: Nutritional Status

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Whey protein and creatine supplement
Dietary Supplement: Whey protein only supplement